Zobrazeno 1 - 10
of 23 880
pro vyhledávání: '"CD8(+) T cells"'
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 1715-1725 (2024)
Li Zhang,1 Juan Chang,2 Xiuwei Wu2 1Department of Obstetrics and Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People’s Republic of China; 2Department of Hematology, Taihe Hospital, Hubei University of Medicine, S
Externí odkaz:
https://doaj.org/article/854acda7ce9e4bc3a93a1ed494660c6e
Publikováno v:
口腔疾病防治, Vol 32, Iss 11, Pp 894-900 (2024)
Neutrophil extracellular traps (NETs) are fibrous web-like structures composed of decondensed chromatin and granular proteins released by neutrophils, with the ability to capture and kill bacteria. Pathogens, such as bacteria and viruses, can trigger
Externí odkaz:
https://doaj.org/article/2661ad5ee6e34b57beca1808b7fbf00f
Publikováno v:
Thoracic Cancer, Vol 15, Iss 32, Pp 2319-2326 (2024)
Abstract Introduction Sex‐determining region Y‐related high‐mobility group box 17 protein (SOX17), a proangiogenic transcription factor, is specifically expressed in tumor endothelial cells (TECs) of implanted Lewis lung carcinoma. However, the
Externí odkaz:
https://doaj.org/article/3efb8e5db128490e9b742b9cdf31de27
Autor:
Loic Vaillant, Waseem Akhter, Jean Nakhle, Matthieu Simon, Martin Villalba, Christian Jorgensen, Marie-Luce Vignais, Javier Hernandez
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Background . CD8+ Cytotoxic T lymphocytes play a key role in the pathogenesis of autoimmune diseases and clinical conditions such as graft versus host disease and graft rejection. Mesenchymal Stromal Cells (MSCs) are multipotent cells with t
Externí odkaz:
https://doaj.org/article/3fbbf7d8d6cb4553818e55ee8beab49b
Autor:
Chaopin Yang, Jinqi You, Yizhi Wang, Si Chen, Yan Tang, Hao Chen, Haoran Zhong, Ruyue Song, Hao Long, Tong Xiang, Ze-Rui Zhao, Jianchuan Xia
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThe use of programmed death-1 (PD-1) inhibitors in the neoadjuvant setting for patients with resectable stage III NSCLC has revolutionized this field in recent years. However, there is still 40%-60% of patients do not benefit from this appr
Externí odkaz:
https://doaj.org/article/177334f45f444b278cae16797a8359d3
Autor:
A. V. Zurochka, M. А. Dobrynina, E. A. Safronova, V. A. Zurochka, A. A. Zuikova, G. P. Sarapultsev, O. I. Zabkov, A. A. Mosunov, M. D. Verkhovskaya, V. V. Ducardt, L. O. Fomina, E. G. Kostolomova, Yu. V. Ostankova, Igor V. Kudryavtsev, A. A. Totolian
Publikováno v:
Инфекция и иммунитет, Vol 14, Iss 4, Pp 756-768 (2024)
Acute COVID-19 is a viral infection caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in dramatically decreased peripheral blood CD3+T cell count apparently due to alterations of thymic T cell maturation, that can
Externí odkaz:
https://doaj.org/article/0daadd10b1a9440a831494249dd39240
Publikováno v:
Cancer Nanotechnology, Vol 15, Iss 1, Pp 1-35 (2024)
Abstract Background The manipulation of CD8+ T cell functions through genetic modifications presents a novel approach to cancer immunotherapy. This study aimed to explore the effects of IL2RG-overexpressing CD8+ T cells and assess the efficacy of del
Externí odkaz:
https://doaj.org/article/dab70318343046e6a5f82d1aec842b47
Autor:
Zihao Zhou, Jiarong Zheng, Ye Lu, Zizhao Mai, Yunfan Lin, Pei Lin, Yucheng Zheng, Xu Chen, Rongwei Xu, Xinyuan Zhao, Li Cui
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-21 (2024)
Abstract CD8+ T cells are integral to the effective management of cancer and infectious diseases due to their cytotoxic functions. The efficacy of these cells is profoundly influenced by their metabolic state, which regulates their activation, differ
Externí odkaz:
https://doaj.org/article/bf49ad5f6f5c4284b1e249956fd8cfa5
Autor:
Ai-Sheng Ho, Jungshan Chang, Shou-Dong Lee, Zong-Lin Sie, Hui-Fen Shih, Chun Yeh, Cheng-Liang Peng, Kapil Dev, Chun-Chia Cheng
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Chronic hepatitis B (CHB) leads to liver inflammation and dysfunction, resulting in liver fibrosis and cancer. Nucleos(t)ide analogues (NAs), inhibitors of hepatitis B virus (HBV), specifically suppress HBV replication. We proposed that immu
Externí odkaz:
https://doaj.org/article/6d068a9de7234b309e2d80c12f855f0d
Publikováno v:
BMC Biotechnology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Hepatitis B virus (HBV) clearance depends on an effective adaptive immune response, especially HBV-specific T cell-mediated cellular immunity; however, it is difficult to produce enough HBV-specific T cells effectively. Results In
Externí odkaz:
https://doaj.org/article/cb644856653b47de9cf946835ec7bbc9